The biphasic regulation, which simultaneously inhibited PKA/AQP3-mediated hyperabsorption and reconstituted Occludin-dependent barrier integrity, provided validation of PCP-g’s dual-targeting efficacy in constipation mitigation, thereby corroborating the mRNA-level observations from Figure 6. The gene discussed is OCLN; the disease is constipation disorder.